SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-031681
Filing Date
2020-11-19
Accepted
2020-11-19 17:44:40
Documents
2
Period of Report
2020-11-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5330
2 EX-24 DOCUMENT attachment1.htm EX-24 4361
  Complete submission text file 0000899243-20-031681.txt   11059
Mailing Address C/O ELEVEN BIOTHERAPEUTICS 215 FIRST STREET, SUITE 400 CAMBRIDGE MA 02142
Business Address
Pfeffer Cary (Reporting) CIK: 0001591092 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37998 | Film No.: 201329840

Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Issuer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)